Definition of a Critical Region on Chromosome 18 for Congenital Aural Atresia by ArrayCGH  by Veltman, Joris A. et al.
Am. J. Hum. Genet. 72:1578–1584, 2003
1578
Report
Definition of a Critical Region on Chromosome 18 for Congenital Aural
Atresia by ArrayCGH
Joris A. Veltman,1 Yvonne Jonkers,1 Inge Nuijten,1 Irene Janssen,1 Walter van der Vliet,1
Erik Huys,1 Joris Vermeesch,3 Griet Van Buggenhout,3 Jean-Pierre Fryns,3 Ronald Admiraal,2
Paulien Terhal,4 Didier Lacombe,5 Ad Geurts van Kessel,1 Dominique Smeets,1
Eric F. P. M. Schoenmakers,1 and Conny M. van Ravenswaaij-Arts1
Departments of 1Human Genetics and 2Oto-Rhino-Laryngology, University Medical Center Nijmegen, Nijmegen, The Netherlands; 3Centre for
Human Genetics, University Hospital Leuven, Leuven, Belgium; 4Department of Medical Genetics, University Medical Centre Utrecht,
Utrecht; and 5Department of Medical Genetics, Pellegrin-Children’s Hospital, Bordeaux
Deletions of the long arm of chromosome 18 occur in ∼1 in 10,000 live births. Congenital aural atresia (CAA),
or narrow external auditory canals, occurs in ∼66% of all patients who have a terminal deletion 18q. The present
report describes a series of 20 patients with CAA, of whom 18 had microscopically visible 18q deletions. The
extent and nature of the chromosome-18 deletions were studied in detail by array-based comparative genomic
hybridization (arrayCGH). High-resolution chromosome-18 profiles were obtained for all patients, and a critical
region of 5 Mb that was deleted in all patients with CAA could be defined on 18q22.3-18q23. Therefore, this
region can be considered as a candidate region for aural atresia. The array-based high-resolution copy-number
screening enabled a refined cytogenetic diagnosis in 12 patients. Our approach appeared to be applicable to the
detection of genetic mosaicisms and, in particular, to a detailed delineation of ring chromosomes. This study clearly
demonstrates the power of the arrayCGH technology in high-resolution molecular karyotyping. Deletion and
amplification mapping can now be performed at the submicroscopic level and will allow high-throughput definition
of genomic regions harboring disease genes.
Congenital aural atresia (CAA) is a rare anomaly, oc-
curring in ∼1 in 10,000 live births (Melnick et al. 1979).
CAA phenotypes may vary from mild symptoms (with
narrowing of the external auditory canal and hypoplasia
of the tympanic membrane and middle ear cavity) to
severe symptoms (including the entire absence of the
middle ear in combination with anotia, bony atresia of
the external auditory canal, and hypoplasia of inner ear
structures) (Cremers et al. 1988; Strathdee et al. 1995).
CAA has been reported frequently in patients with
chromosomal anomalies, especially deletions on the long
arm of chromosome 18 (18q) (de Grouchy et al. 1964;
Kline et al. 1993; Keppler-Noreuil et al. 1998; Cody et
al. 1999). The exact region on 18q that is involved in
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CAA is unclear, as most patients have terminal deletions
starting at 18q23 (Schinzel 2001), but also patients with
interstitial deletions of 18q21 or 18q22 have been re-
ported (Wilson et al. 1979; Schinzel et al. 1991). In the
present study, we employed arrayCGH to define a CAA-
associated shortest region of deletion overlap on chro-
mosome 18.
For this purpose, a high resolution chromosome-18
array was constructed using DOP-PCR (Telenius et al.
1992) products from 114 positionally selected and com-
mercially obtained (BACPACResources) chromosome-18
BAC clones, covering the chromosome with an average
spacing of one clone per 670 kb. The average clone-
insert size is 175 kb, which results in a total chromosome-
18 coverage of 26%. The chromosome-18 copy-number
profile of 20 patients with CAA (18 withmicroscopically
visible 18q deletions [Nuijten et al., in press]) was estab-
lished through hybridization of the arrays with cy3-la-
beled patient-derived DNAs combined with cy5-labeled
control-derived DNAs. After scanning, fluorescence ratios
were determined for each clone. Ratios indicating copy-
number gains or losses were compared with the original
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Figure 2 Overview of all arrayCGH intensity ratios for the 20 patients with CAA. Arrays contained 114 cloned chromosome-18 genomic
DNA targets, ordered from pter to qter on the basis of physical mapping positions obtained from the June 2002 freeze of the UCSC genome
browser. Ratios above the threshold of copy-number gain (1.2) are color coded in light green; ratios below the threshold of copy-number loss
(0.8) are color coded in orange. Note the deletion zone on the q arm of chromosome 18, with a minimal region of deletion present in 19 of
the 20 patients in the region on 18q22.3-18q23. Mosaicism for the 18q deletion was present in patients 2 and 19. No intensity ratio is depicted
if a clone did not pass the inclusion criteria in a particular experiment.
cytogenetic data on the basis of karyotyping (figs. 1 and
2; table 1). On the basis of the control experiments and
work published elsewhere (Veltman et al. 2002; Wilhelm
et al. 2002), thresholds for copy-number gain and loss
were set at 1.2 and 0.8, respectively. As a representative
example, figure 1B shows the arrayCGH profile of pa-
tient 5, with karyotype:46,XY,del(18)(q21.31). A nor-
mal intensity ratio was observed for all clones mapping
from 18pter to 18q21.31, whereas ratios !0.8 were con-
sistently observed from 18q21.31-18qter.
In 19 of the 20 patients tested, copy-number losses
involving part of the q arm were identified (mean fluo-
rescence ratio of the deleted region 0.68; for overview of
the results see table 1 and fig. 2). The size of the deletion
varied considerably in these cases,with the largest deletion
encompassing 44 clones mapping to 18q21.31-18qter
(23-Mb deletion, patient 1) and the smallest deletion en-
compassing 13 clones mapping to 18q22.3-18q23 (6-Mb
deletion, patient 18). In two patients, copy-number al-
terations were observed on the p arm as well, in agree-
ment with the cytogenetic diagnosis; patient 17 carries
a ring chromosome involving part of the p arm, and
patient 18 carries a complex translocation involving a
duplication of 18p11-pter.
The arrayCGH approach, in most cases, resulted in a
more precise delineation of the deleted region, and,
therefore, the cytogenetic diagnosis could be refined in
12 of the 20 patients with CAA (table 1): 7 patients with
a terminal deletion, 2 patients with a ring chromosome,
2 patients with a translocation, and 1 patient with a pre-
viously unidentified submicroscopic terminal deletion.
This study illustrates the added value of the arrayCGH
technology for studying the genomic content of, espe-
cially, ring chromosomes and complex translocations.
In patient 18, an interstitial 18q22.3-18q23 deletion
was identified by arrayCGH, which was not observed
in the original karyotypic analysis. This subject with a
complex translocation between chromosomes 7 and 18
was previously studied using routine karyotyping and
FISH with probes for 7qter, 18pter, and 18qter, as well
as whole chromosome arm paints for 18p and 18q. On
the basis of these analyses, the following karyotype was
established: 46,XY,der(7)t(7;18)(q36.1;q23),der(18)
(pterrq23:p11.2rpter). However, since this patient had
a meatus atresia, a deletion directly flanking the 18q
breakpoint was suspected and, subsequently, proven in
the present study by arrayCGH. Consequently, the kar-
yotype has been adjusted to 46,XY,der(7)t(7;18)(q36.1;
q23),der(18)(pterrq22.3::p11.2rpter), with a deletion
of 18q22.3q23 and a duplication of 18p11.21pter. Sim-
ilarly, in patient 20, a terminal deletion of 18q22.3 was
identified by arrayCGH, whereas no cytogenetic abnor-
malities were observed in the original karyotypic anal-
ysis. Subject 20 was presented in 2002 as a patient with
Rasmussen syndrome: a combination of external audi-
tory canal atresia, club feet, and hypertelorism (Julia et
al. 2002). This patient had many features in common
with patients with a terminal deletion of 18q; besides
CAA, hypertelorism, and club feet, she had a low im-
plantation of the thumbs and a typical shape of the ear
with prominent crus helix. The latter is very typical for
patients with a terminal 18q deletion. Of note, the girl
exhibited a normal mental development. She had the
smallest terminal deletion of all cases in our series. Since
the deletion was not seen by routine karyotyping, an
unbalanced cryptic translocation should be excluded. At
this writing, the parents are under investigation to test
for the possible presence of a balanced cryptic translo-
cation in either of them.
Patient 18 was the only case with an interstitial 18q
deletion as observed by arrayCGH. All other cases
showed terminal 18q deletions. The presence of an in-
terstitial deletion and one normal copy of the terminal
part of 18q in this patient was validated by FISH, by use
of clones also present on the array (fig. 3). FISH validation
was also performed for patient 15, with a translocation
involving chromosomes 18 and X. In both cases, the
arrayCGH findings were independently confirmed.
In one case (patient 19), no deletion was identified by
arrayCGH. Cytogenetically, however, an 18q21.3-qter
deletion was observed in 33% of the cells. The mean
ratio of the clones mapping to this deletion region was
0.86, and 5 clones mapping to this region showed ratios
below the threshold of 0.8 (fig. 2). One other case (pa-
tient 2) with a genetic mosaicism was included in this
study; in this patient, ∼75% of the cells carried the 18q
deletion. This deletion could clearly be identified by ar-
rayCGH, although the mean fluorescence ratios of the
deleted clones were slightly higher than in cases with
deletions in 100% of the cells (mean fluorescence ratio
of deleted clones in this mosaic case was 0.72, compared
with 0.68 for nonmosaic deletion cases; see fig. 2). This
observation is in agreement with a study reported else-
where dealing with the influence of normal genomicDNA
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Figure 3 FISH validation experiments. FISH validation experiments were performed for patients 15 (A) and 18 (B). The original karyotype
of patient 15 is 46,X,del(X)(q21.2),der(18)t(X:18)(q21.1;q22), and that of patient 18 is 46,XY,der(7)t(7;18)(q36.1;q23),der(18)(pter-q23::p11.2-
pter). A, The deleted 18q22.3 clone RP11-90L15 is labeled in red, the normal 18q21.33 clone RP11-75O12 in green. The normal chromosome
18 contains both clones in the correct order, whereas, on the derivative chromosome 18, only clone RP11-75O12 is present, thus confirming
the unbalanced translocation as identified by both arrayCGH and karyotyping. B, The deleted 18q22.3 clone RP11-90L15 is labeled in green,
the normal 18q23 clone RP11-91C19 in red. The normal chromosome 18 contains both clones in the correct order, whereas, in the derivative
chromosome 7, only clone RP11-91C19 is present. The deletion is visible both in metaphase and in interphase (inset), thus confirming the
unbalanced translocation as identified by arrayCGH but not by karyotyping.
contamination on the detection of single copy-number
abnormalities in murine islet carcinomas by arrayCGH
(Hodgson et al. 2001). In general, it can be stated that
at least 50% of the cells should contain a single copy-
number change to allow reliable detection by arrayCGH.
After integrating all data, one common genomic region
could be defined that was deleted in all patients with CAA
(fig. 2). The proximal deletion breakpoint maps between
clone RP11-90L15 (70.6 Mb) and clone RP11-358A5
(71.3 Mb), whereas the distal deletion breakpoint resides
between clone RP11-958C14 (76.2Mb) and clone RP11-
91C19 (77.0 Mb). This smallest region of deletion over-
lap has an approximate size of 5 Mb and is located on
18q22.3-18q23. This critical deletion regionmay be nar-
rowed further on the basis of the work by Strathdee et
al. (1997), showing a telomeric deletionwith the proximal
deletion breakpoint mapping between STSs D18S489
(72.6 Mb) and D18S1121 (72.9 Mb). A combination of
our results with that study indicates that the minimal
deletion region can be limited to !4 Mb. One or more
genes related to aural atresia are likely to be located in
this particular interval. There are well 140 transcribed
sequences located in this 4-Mb region, including seven
known protein coding genes. One of the candidate genes
in this region is myelin basic protein, for which a role
in the mental retardation phenotype associated with the
18q- syndrome has been postulated (Weiss et al. 1991).
Other well-annotated genes include ZNF236, a glucose-
regulated Kruppel-like zinc-finger gene potentially in-
volved in diabetic nephropathy (Holmes et al. 1999);
GALR1, galanin receptor-1, which belongs to a family
of G protein–coupled receptors for the neuropeptide gal-
anin (Lismaa et al. 1998); and SALL3, another zinc-
finger gene of the human spaltlike gene family (Kohlhase
et al. 1999).
The present study underscores the power of the array-
CGH technology, which is rapidly becoming the method
of choice for high-resolution screening of genomic copy-
number changes (Solinas-Toldo et al. 1997; Pinkel et al.
1998; Pollack and Iyer 2002; Veltman et al. 2002). High-
resolution karyotyping identifies 19 cytogenetic bands for
chromosome 18 (∼1 band every 4 Mb). In this particular
chromosome-18 array, the average clone spacing was 670
kb, which resulted in a resolution that is a factor 6
higher, as compared with high-resolution karyotyping.
Systematic, whole-genome deletion mapping can now be
performed at the submicroscopic level, allowing the iden-
tification of microdeletions potentially harboring target
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Table 1
Patients with CAA, Karyotypes, and Results of Chromosome-18 Profiling by ArrayCGH
Patient CAAa Conventional Karyotype ArrayCGH-Based Karyotype
1 NAC 46,XY,del(18)(q21.2) del(18)(q21.31)b
2 NAC 46,XY,del(18)(q21.3) in 75% of cells del(18)(q21.31)b
3 NAC 46,XX,del(18)(q21.31) del(18)(q21.31)
4 NAC 46,XX,del(18)(q21.31) del(18)(q21.31)
5 NAC 46,XY,del(18)(q21.31) del(18)(q21.31)
6 MA 46,XY,del(18)(q21.31) del(18)(q21.31)
7 NAC 46,XY,r(18)(p11q21.31) del(18)(q21.31)
8 NAC 46,XX,del(18)(q21.3) del(18)(q21.32)b
9 MA 46,XX,r(18)(pterq23) del(18)(q21.32)b
10 NAC 46,XY,del(18)(q21.3) del(18)(q21.33)b
11 NAC 46,XY,del(18)(q22) del(18)(q22.1)b
12 MA 46,XX,del(18)(q22.1) del(18)(q22.1)
13 NAC 46,XX,del(18)(q22.3) del(18)(q22.1)b
14 NAC 46,XX,del(18)(q22.1) del(18)(q22.1)
15 NAC 46,X,del(X)(q21.2), der(18)t(X :18)(q21.2;q22) del(18)(q22.3)b
16 MA 46,XY,del(18)(q22.2) del(18)(q22.3)b
17 NAC 46,XX,r(18)(p11q23) del(18)(p11.21)  del(18)(q22.3)b
18 MA 46,XY,der(7)t(7;18)(q36.1;q23),der(18)(pterrq23::p11.2rpter) gain(18)(p11.21)  del(18)(q22.3q23)b
19 MA 46,XY,del(18)(q21.3) in 33% of cells No copy-number change detected
20 MA 46,XXc del(18)(q22.3)b
a NAC p narrow external auditory canals; MA p meatus atresia.
b Cases in which arrayCGH refined the initial cytogenetic diagnosis.
c Julia et al. 2002.
disease genes, like the 5-Mb deletion on 18q22.3-18q23
described in the present study. To further narrow the
critical region for CAA, we are currently screening pa-
tients with CAA without any apparent cytogenetic ab-
normalities on chromosome 18, as well as patients with
balanced translocations affecting this region.
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